NDSN · Nordson Corp
Market Cap
$17.68B
Shares
55.70M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$2.79B
+3.8%
FY2025
Net Income
$484.47M
+3.7%
FY2025
Gross Margin
55.16%
-0.1pp
FY2025
Operating Margin
25.49%
+0.4pp
FY2025
Diluted EPS
$8.51
+4.9%
FY2025
Operating Cash Flow
$719.18M
+29.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $2.98B | $2.79B | $2.69B | $2.63B | $2.59B | $2.36B | $2.12B | $2.19B | $2.25B | $2.07B | $1.81B | $1.69B | $1.7B | $1.54B | $1.41B | $1.23B | $1.04B | $819.17M | $1.12B | |
| — | $1.33B | $1.25B | $1.2B | $1.2B | $1.16B | $1.04B | $990.63M | $1B | $1.02B | $927.69M | $815.5M | $774.7M | $758.92M | $676.78M | $586.29M | $484.73M | $419.94M | $350.24M | $494.39M | |
| — | $1.65B | $1.54B | $1.49B | $1.43B | $1.43B | $1.32B | $1.13B | $1.19B | $1.24B | $1.14B | $993.5M | $913.96M | $945.1M | $866.14M | $823.29M | $748.43M | $621.61M | $468.93M | $630.44M | |
| — | — | 55.16% | 55.25% | 54.23% | 55.07% | 56.05% | 53.3% | 54.33% | 54.83% | 55.12% | 54.92% | 54.12% | 55.46% | 56.14% | 58.41% | 60.69% | 59.68% | 57.24% | 56.05% | |
| — | — | $68.24M | $64.99M | $71.4M | $52.53M | $59.42M | $63.59M | $60.02M | $58.81M | $52.46M | $46.25M | $46.69M | $47.54M | $47.97M | $36.54M | $27M | $23.84M | $25.53M | — | |
| — | $846.1M | $815.51M | $812.13M | $752.64M | $724.18M | $708.95M | $693.55M | $708.99M | $733.75M | $672.89M | $605.07M | $584.82M | $575.44M | $541.17M | $487.81M | $429.49M | $384.75M | $337.29M | $434.48M | |
| — | $78.48M | $79.26M | $76.97M | $59.72M | $50.83M | $50.55M | $56.98M | $54.79M | $55.45M | $44.91M | $29.06M | $27.49M | $25.31M | $22.67M | $14.52M | $8.02M | — | — | — | |
| — | $76.26M | $79.26M | $76.97M | $59.72M | $99.92M | $103.88M | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | $39K | $5.21M | — | — | — | — | — | — | — | — | |
| — | — | $2.08B | $2.02B | $1.96B | $1.89B | $1.75B | $1.77B | $1.71B | $1.75B | $1.6B | $1.42B | $1.37B | $1.34B | $1.22B | $1.07B | $917.62M | $806.72M | $946.97M | $934.49M | |
| — | $800.96M | $711.73M | $674M | $672.76M | $702.36M | $615.13M | $349.55M | $483.11M | $502.58M | $466.4M | $388.43M | $317.73M | $367.11M | $323.85M | $335.48M | $315.54M | $234.83M | -$127.81M | $190.34M | |
| — | — | 25.49% | 25.06% | 25.59% | 27.12% | 26.04% | 16.48% | 22.02% | 22.29% | 22.56% | 21.47% | 18.82% | 21.54% | 20.99% | 23.8% | 25.59% | 22.55% | -15.6% | 16.92% | |
| — | $877.22M | $790.99M | $750.97M | $732.48M | $802.28M | $719.01M | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | $90.66M | $104.16M | $88.92M | $59.51M | $22.41M | $25.49M | $32.16M | $47.15M | $49.58M | $36.6M | $21.32M | $18.1M | $15.04M | $14.84M | $11.15M | $5.07M | $6.26M | $7.77M | $16.71M | |
| — | $2.21M | $3.05M | $4.91M | $2.68M | $2.03M | $2.15M | $1.68M | $1.84M | $1.38M | $1.12M | $728K | $558K | $581K | $421K | $463K | $569K | $819K | $492K | $1.25M | |
| — | -$115.05M | -$114.08M | -$88.52M | -$57.42M | -$53.08M | -$40.95M | -$48.06M | -$52.01M | -$54.06M | -$46.11M | -$19.94M | -$16.87M | -$14.59M | -$12.73M | -$9.23M | -$982K | -$3.51M | $616K | -$10.55M | |
| — | $674.51M | $597.65M | $585.48M | $615.34M | $649.28M | $574.18M | $301.49M | $431.1M | $448.52M | $420.29M | $368.49M | $300.86M | $352.51M | $311.12M | $326.25M | $314.56M | $231.32M | -$127.19M | $179.79M | |
| — | $119.34M | $113.17M | $118.2M | $127.85M | $136.18M | $119.81M | $51.95M | $94.01M | $71.14M | $124.49M | $96.65M | $89.75M | $105.74M | $89.31M | $101.42M | $92.2M | $63.27M | $32.86M | $62.28M | |
| — | $555.18M | $484.47M | $467.28M | $487.49M | $513.1M | $454.37M | $249.54M | $337.09M | $377.38M | $295.8M | $271.84M | $211.11M | $246.77M | $221.82M | $224.83M | $222.36M | $168.05M | -$160.06M | $117.5M | |
| — | — | 17.35% | 17.37% | 18.55% | 19.81% | 19.23% | 11.76% | 15.36% | 16.74% | 14.31% | 15.03% | 12.5% | 14.48% | 14.38% | 15.95% | 18.03% | 16.13% | -19.54% | 10.45% | |
| — | $641.75M | $568.86M | $478.89M | $498.83M | $481.16M | $504.65M | $255.3M | $284.52M | $332.5M | $329.61M | $248.28M | $169.62M | $200.95M | $268.66M | $200.62M | $208.66M | $157.21M | -$174.73M | $68.51M | |
| USD/shares | — | $9.92 | $8.56 | $8.17 | $8.54 | $8.90 | $7.82 | $4.32 | $5.87 | $6.51 | $5.14 | $4.76 | $3.48 | $3.88 | $3.45 | $3.49 | $3.29 | $2.49 | -$2.38 | $3.48 |
| USD/shares | $11.80 – $12.00* | $9.87 | $8.51 | $8.11 | $8.46 | $8.81 | $7.74 | $4.27 | $5.79 | $6.40 | $5.08 | $4.73 | $3.45 | $3.84 | $3.42 | $3.45 | $3.25 | $2.46 | -$2.38 | $3.43 |
| shares | — | — | 56.61M | 57.18M | 57.09M | 57.63M | 58.09M | 57.76M | 57.46M | 57.97M | 57.53M | 57.06M | 60.65M | 63.66M | 64.21M | 64.41M | 67.62M | 67.61M | 67.13M | 33.75M |
| shares | — | — | 56.92M | 57.62M | 57.63M | 58.25M | 58.73M | 58.47M | 58.2M | 58.93M | 58.2M | 57.53M | 61.15M | 64.28M | 64.91M | 65.1M | 68.43M | 68.44M | 67.13M | 34.31M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2008–FY2025: $1.86B in buybacks, $1.36B in dividends.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Coverage backlog: 52 eligible filings and 0 covenant artifacts have no current-version terminal extraction result. This includes untouched sources and sources on the retry ladder.
No terminal debt extraction result is available yet; this is not evidence that the company has no debt.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
6.48×
Peer median 3.34×
EV/EBIT
24.10×
Peer median 21.78×
P/E (TTM)
32.17×
Peer median 31.43×
Peer medians compare against the 40 similar-size Specialty Industrial Machinery companies (of 73 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Industrial Precisions Solutions | $1,331,792,000 | $1,398,912,000 | $1,297,070,000 | $1,337,242,000 | $1,246,947,000 | $1,143,423,000 | — | — |
| Medical Fluid Systems | $835,385,000 | $695,452,000 | $660,316,000 | $690,177,000 | $641,654,000 | $564,899,000 | — | — |
| Advanced Technology Systems | $624,510,000 | $595,557,000 | $671,246,000 | $562,859,000 | $473,608,000 | $412,778,000 | $985,850,000 | $1,039,366,000 |
| Adhesive Dispensing Systems | — | — | — | — | — | — | $1,208,376,000 | $1,215,302,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Americas | $1,205,830,000 | $1,178,626,000 | $1,149,760,000 | — | — | — | — | — |
| United States | $922,733,000 | $899,421,000 | $888,405,000 | — | — | — | $758,383,000 | $720,832,000 |
| Asia Pacific Excluding Japan | $863,636,000 | $785,195,000 | $796,196,000 | $848,079,000 | $775,607,000 | $687,349,000 | $569,830,000 | $591,120,000 |
| Europe | $722,221,000 | $726,100,000 | $682,676,000 | $645,603,000 | $617,492,000 | $536,636,000 | $571,596,000 | $622,108,000 |
| Japan | — | — | — | — | — | — | $126,756,000 | $161,771,000 |
| Americas Excluding US | — | $1,178,626,000 | $1,149,760,000 | $1,096,596,000 | $969,110,000 | $897,115,000 | $167,661,000 | $158,837,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Industrial Precisions Solutions | $470,559,000 | $460,889,000 | $434,476,000 | $414,192,000 | $208,028,000 | — | — |
| Medical Fluid Systems | $187,731,000 | $189,367,000 | $217,199,000 | $198,194,000 | $150,296,000 | — | — |
| Advanced Technology Systems | $94,231,000 | $101,662,000 | $133,253,000 | $73,466,000 | $41,306,000 | $205,609,000 | $244,880,000 |
| Adhesive Dispensing Systems | — | — | — | $414,192,000 | $208,028,000 | $329,054,000 | $315,048,000 |
Operating Margin by Segment (%)
| Component | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Industrial Precisions Solutions | 33.6% | 35.5% | 32.5% | 33.2% | 18.2% | — | — |
| Medical Fluid Systems | 27% | 28.7% | 31.5% | 30.9% | 26.6% | — | — |
| Advanced Technology Systems | 15.8% | 15.1% | 23.7% | 15.5% | 10% | 20.9% | 23.6% |
| Adhesive Dispensing Systems | — | — | — | — | — | 27.2% | 25.9% |
Key facts
CIK
72331
CUSIP
655663102
13F (30d)
446 filings
432 filers
Visit website
Investor relations